Form 4: Rapport Therapeutics Director Receives Stock Option Grant

Director Robert J. Perez was granted 15,200 stock options in Rapport Therapeutics, Inc. as part of standard equity compensation.

Summary

• Director Robert J. Perez received a grant of 15,200 stock options for Rapport Therapeutics, Inc. (RAPP).
• The options have an exercise price of $35.21 per share.
• The grant date is June 10, 2026, with an expiration date of June 10, 2036.
• The options are subject to a vesting schedule based on the earlier of one year or the next annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• The grant results in potential future dilution for existing shareholders upon exercise.

Risks

• Market volatility affecting the value of the underlying common stock relative to the $35.21 exercise price.

Future Outlook

The options vest on the earlier of June 10, 2027, or the date of the next Annual Meeting of Stockholders, contingent upon continued service.

Management Comments

• No specific management commentary provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the biotechnology sector to attract and retain board expertise.

Comparison to Industry Standards

• The grant size and vesting terms are consistent with standard corporate governance practices for mid-cap biotechnology firms.
• The use of time-based vesting aligns with typical director compensation structures seen in peers like Sage Therapeutics or Karuna Therapeutics.

Corporate Governance

Stakeholder Impact

• Minor dilution impact on existing shareholders upon future exercise of options.

Next Steps

• Vesting of options on June 10, 2027, or the next Annual Meeting of Stockholders.

Key Dates

Keywords

Rapport Therapeutics, RAPP, Form 4, Insider Trading, Stock Options, Director Compensation